Sunday, January 27, 2019 2:08:03 PM
The Lawman - thank you for your answer , I too always enjoy reading your posts .. thank you .,
-my “ unwavering support “ for the comp as you said has a reasons ,
This is because of all medical results I see ..
I am almost 50% down in my portfolio , I am here little over 3 years , and if not what I see in science I will long time ago take my losses and leave , and stop posting here .
If you see my post history since 2003 on ihub , my posting here and my enthusiasm is not very common for me , actually this is first time in my life !!!
But this is first time I am so excited about drug so much !!!
You have generally very many very good points in your posts , but my evaluation of medicine here will not let me forget dr NP input , I believe that without him Pro 140 will still be someplace on the shelf ..
And when I see how many hrs dr NP giving to the company , even his salary stopped bother me ..
No , I don’t think that I have a blind loyalty to dr NP , I spend a lot of my time every single day to read about our and others science , and mostly this what I go by .,
Thank you again for your post , I know that all together we are on the same side , I believe that you much better business man , and I might be little better physician ..:))
Like you I believe that ending is looking better and better .
My best to you .
-my “ unwavering support “ for the comp as you said has a reasons ,
This is because of all medical results I see ..
I am almost 50% down in my portfolio , I am here little over 3 years , and if not what I see in science I will long time ago take my losses and leave , and stop posting here .
If you see my post history since 2003 on ihub , my posting here and my enthusiasm is not very common for me , actually this is first time in my life !!!
But this is first time I am so excited about drug so much !!!
You have generally very many very good points in your posts , but my evaluation of medicine here will not let me forget dr NP input , I believe that without him Pro 140 will still be someplace on the shelf ..
And when I see how many hrs dr NP giving to the company , even his salary stopped bother me ..
No , I don’t think that I have a blind loyalty to dr NP , I spend a lot of my time every single day to read about our and others science , and mostly this what I go by .,
Thank you again for your post , I know that all together we are on the same side , I believe that you much better business man , and I might be little better physician ..:))
Like you I believe that ending is looking better and better .
My best to you .
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
